Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
san francisco
san francisco blog main
3
×
san francisco top stories
startups
3
×
biotech
medical devices
new york blog main
new york top stories
san diego blog main
san diego top stories
accelerator
acetylon pharmaceuticals
airbnb
alphabet
amazon web services (aws)
ambys medicines
artificial intelligence (a.i.)
athelas
atomwise
benchling
biotechnology
broad institute of harvard and mit
brook byers
cancer
cell therapy
charles chu
coinbase
constellation pharmaceuticals
coworking
crispr
crispr cas14
cruise
culture biosciences
data analytics
What
big
3
×
startup
today
admits
ago
aiming
ambys
available
based
bio
biosciences
biotech
biotechs
cas
cheaper
classes
combinator
companies
control
crispr
deadly
deal
debuted
develop
diagnostics
diseases
dug
expects
faster
formed
future
incubator
launch
life
liver
make
mammoth
medicines
new
previously
Language
unset
Current search:
big
×
startups
×
" san francisco blog main "
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?